GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) saw a large growth in short interest during the month of June. As of June 15th, there was short interest totaling 13,609 shares, a growth of 219.0% from the May 31st total of 4,266 shares. Approximately 0.5% of the company’s stock are short sold. Based on an average daily volume of 16,719 shares, the short-interest ratio is currently 0.8 days.
GMO U.S. Value ETF Stock Performance
Shares of GMO U.S. Value ETF stock traded up $0.30 during trading on Friday, reaching $30.17. The company had a trading volume of 3,983 shares, compared to its average volume of 15,650. GMO U.S. Value ETF has a fifty-two week low of $24.79 and a fifty-two week high of $30.57. The firm’s fifty day moving average is $29.83 and its 200-day moving average is $28.85. The company has a market cap of $87.49 million, a price-to-earnings ratio of 12.08 and a beta of 0.64.
Hedge Funds Weigh In On GMO U.S. Value ETF
Several large investors have recently added to or reduced their stakes in the company. Fifth Third Bancorp acquired a new position in GMO U.S. Value ETF in the first quarter worth $84,000. Kestra Private Wealth Services LLC acquired a new stake in shares of GMO U.S. Value ETF during the first quarter worth $333,000. Aspen Investment Management Inc bought a new position in shares of GMO U.S. Value ETF in the 4th quarter worth about $333,000. RPS Advisory Solutions LLC bought a new position in shares of GMO U.S. Value ETF in the 4th quarter worth about $484,000. Finally, J.W. Cole Advisors Inc. boosted its holdings in shares of GMO U.S. Value ETF by 128.7% in the 4th quarter. J.W. Cole Advisors Inc. now owns 28,510 shares of the company’s stock valued at $784,000 after buying an additional 16,044 shares during the period.
About GMO U.S. Value ETF
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
Featured Articles
- Five stocks we like better than GMO U.S. Value ETF
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
